» Articles » PMID: 29372285

Comparison of Inflammatory Urine Markers in Patients with Interstitial Cystitis and Overactive Bladder

Overview
Publisher Springer
Date 2018 Jan 27
PMID 29372285
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction And Hypothesis: Chronic inflammatory conditions seem to be a shared characteristic in patients with interstitial cystitis (IC) and overactive bladder (OAB). Thus, we measured 40 inflammatory urine markers in IC patients with or without Hunner's lesions (HIC and NHIC respectively) and OAB patients.

Methods: Urine was collected from consecutive HIC patients, NHIC patients, and age and gender-matched OAB patients with no history of IC, recurrent urinary tract infection or bladder cancer. The diagnosis of IC was based on the Asian IC guideline criteria. A representative 40 inflammatory growth factors, cytokines, and chemokines in urine were measured using a MILLIPLEX immunoassay kit. Statistical differences in these markers among the groups were determined by nonparametric ANOVA followed by multiple comparison test. The diagnostic efficiency of these markers was measured using receiver operating characteristic analysis.

Results: Vascular endothelial growth factor (VEGF), interleukin-1α (IL-1α), IL-6, and chemokines including CCL2, CCL5, CXCL1, CXCL8, and CXCL10 were significantly increased in HIC (n = 30) and NHIC (n = 30) patients compared with OAB (n = 28) patients. The significant increases in CXCL8 and CXCL10 were also found in HIC patients compared with NHIC patients. However, there were no significant differences in the other urine markers among the groups. Area under the curves for VEGF, CXCL10, CXCL8, IL-1α, CCL5, CCL2, IL-6, and CXCL1 to detect IC in these patients were 0.87, 0.86, 0.81, 0.80, 0.80, 0.71, 0.66, and 0.50 respectively.

Conclusions: The increases in angiogenesis-associated proteins such as VEGF and CXCL10 may be pathophysiologically important for the development of IC.

Citing Articles

Integrating biomarker clustering for improved diagnosis of interstitial cystitis/bladder pain syndrome: a review.

Chen Y, Kuo H Int Urol Nephrol. 2025; .

PMID: 40088357 DOI: 10.1007/s11255-025-04452-y.


Focal or diffuse bladder wall thickness on bladder computed tomography indicates more severe bladder wall inflammation in patients with interstitial cystitis.

Yu W, Jiang Y, Jhang J, Kuo H World J Urol. 2025; 43(1):100.

PMID: 39903306 DOI: 10.1007/s00345-025-05451-5.


Advancing Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Diagnosis: A Comparative Analysis of Machine Learning Methodologies.

Janicki J, Zwaans B, Bartolone S, Ward E, Chancellor M Diagnostics (Basel). 2024; 14(23).

PMID: 39682641 PMC: 11640490. DOI: 10.3390/diagnostics14232734.


The exposure to volatile organic compounds associate positively with overactive bladder risk in U.S. adults: a cross-sectional study of 2007-2020 NHANES.

Zhang D, Yan Z, He J, Yao Y, Liu K Front Public Health. 2024; 12:1374959.

PMID: 38912261 PMC: 11190323. DOI: 10.3389/fpubh.2024.1374959.


Th1/17 polarization and potential treatment by an anti-interferon-γ DNA aptamer in Hunner-type interstitial cystitis.

Akiyama Y, Harada K, Miyakawa J, Kreder K, ODonnell M, Daichi M iScience. 2023; 26(11):108262.

PMID: 38026177 PMC: 10663743. DOI: 10.1016/j.isci.2023.108262.


References
1.
van de Merwe J, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha L . Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2007; 53(1):60-7. DOI: 10.1016/j.eururo.2007.09.019. View

2.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U . The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002; 21(2):167-78. DOI: 10.1002/nau.10052. View

3.
Lazarus A, Keshet E . Vascular endothelial growth factor and vascular homeostasis. Proc Am Thorac Soc. 2011; 8(6):508-11. DOI: 10.1513/pats.201102-021MW. View

4.
Strieter R, Kunkel S, Arenberg D, Burdick M, Polverini P . Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun. 1995; 210(1):51-7. DOI: 10.1006/bbrc.1995.1626. View

5.
Ammit A, Lazaar A, Irani C, ONeill G, Gordon N, Amrani Y . Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Am J Respir Cell Mol Biol. 2002; 26(4):465-74. DOI: 10.1165/ajrcmb.26.4.4681. View